Next Article in Journal
Multiplicity and the Marginal Benefits of Bevacizumab in Malignant Solid Tumours
Previous Article in Journal
Report from the 20th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28–29 September 2018
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Meeting Report

African–Caribbean Cancer Consortium Scientific and Training Conference 2017

1
Cancer Prevent ion and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA
2
African–Caribbean Cancer Consortium, Philadelphia, PA, USA
3
Capstone College of Nursing, The University of Alabama, Tuscaloosa, AL, USA
4
California State University, Monterey Bay, Seaside, CA, USA
5
Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, USA
6
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
7
Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
8
Partnership for Public Engagement, The Valley, Anguilla
9
Department of Surgery, University of the West Indies, Mona, Kingston, Jamaica
10
North West Regional Health Authority, Port-of-Spain, Trinidad and Tobago
11
School of Clinical Medicine and Research, University of the West Indies, Nassau, Bahamas
12
Department of Community Health and Psychiatry, University of the West Indies, Mona, Kingston, Jamaica
13
African–Caribbean Cancer Consortium, Tobago, Trinidad and Tobago
14
Kenya Medical Research Institute, Nairobi, Kenya
15
Liberia National Cancer Registry, Monrovia, Liberia
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(6), 785-790; https://doi.org/10.3747/co.26.5305
Submission received: 10 September 2019 / Revised: 9 October 2019 / Accepted: 7 November 2019 / Published: 1 December 2019

Abstract

The sixth International African–Caribbean Cancer Consortium (AC3) Conference was held 6–9 October 2017 in Miami, Florida, U.S.A. The conference was open to all researchers, trainees, clinical and public health professionals, and community members, and served as an international hub for the United States, the Caribbean, and Africa. Sessions included AC3 collaboration meetings, cancer surveillance and research skills training workshops, and a community cancer prevention conference.
Keywords: disparities disparities

Share and Cite

MDPI and ACS Style

Ragin, C.; Oliver, J.S.; Cabral, D.N.; Harlemon, M.; Louden, D.; Morrison-Blidgen, B.F.; Alleyne-Mike, K.; Ashing, K.; Butler, R.; Gathere, S.; et al. African–Caribbean Cancer Consortium Scientific and Training Conference 2017. Curr. Oncol. 2019, 26, 785-790. https://doi.org/10.3747/co.26.5305

AMA Style

Ragin C, Oliver JS, Cabral DN, Harlemon M, Louden D, Morrison-Blidgen BF, Alleyne-Mike K, Ashing K, Butler R, Gathere S, et al. African–Caribbean Cancer Consortium Scientific and Training Conference 2017. Current Oncology. 2019; 26(6):785-790. https://doi.org/10.3747/co.26.5305

Chicago/Turabian Style

Ragin, C., J. S. Oliver, D. N. Cabral, M. Harlemon, D. Louden, B. F. Morrison-Blidgen, K. Alleyne-Mike, K. Ashing, R. Butler, S. Gathere, and et al. 2019. "African–Caribbean Cancer Consortium Scientific and Training Conference 2017" Current Oncology 26, no. 6: 785-790. https://doi.org/10.3747/co.26.5305

Article Metrics

Back to TopTop